Dapsone (4,4 diaminodiphenyl sulphone) is a standard drug used in treatment of leprosy in India. While chronic toxicity is not uncommon, I it is a rare cause of acute poisoning. We present a case of acute dapsone toxicity in a patient who consumed about 3 grams of dapsone with the intention of committing suicide and developed methaemoglobinaemia, delayed onset sulphaemoglobinaemia and liver dysfunction.
CASE HISTORY
A 21-year-old male patient undergoing treatment for leprosy consumed a "handful" of dapsone tablets (about 30 tablets of 100 mg each) and came to the ophthalmology clinics to donate his eyes after his death. He complained of restlessness, giddiness and difficulty in breathing and was shifted to the Intensive Care Unit (lCU). On examination the patient was conscious, oriented and obeying verbal commands. He had a tachycardia (130-140/min), tachypnoea (40-441 min), normal blood pressure with peripheral and central cyanosis. An intravenous line was established and the blood withdrawn was chocolate brown in colour. The blood did not change its colour when oxygen was bubbled through it. A diagnosis of methaemoglobinaemia secondary to dapsone ingestion was made and samples were sent for investigations. Continuous ECG and noninvasive blood pressure monitoring was established. The oxygen saturation measured by pulse oximetry was 68-70070 and arterial blood gas analysis revealed hypoxaemia ( Table 1 ). Oxygen therapy was then initiated using a venturi mask (Fi02 0.5). Right internal jugular cannulation revealed a CVP of 9 cm H2O. Gastric lavage was performed using two litres of saline. Activated charcoal (25 gm) was administered to reduce gut absorption. An infusion of ascorbic acid (1.0 g) in 5070 dextrose solution was given over 20 minutes. Methylene blue 50 mg (1.0 mg/kg) was infused as a 1070 solution over five minutes. On institution of methylene blue infusion, an initial fall in S p 02 from 75070 to 68070 was noticed, followed by a rise to 84-86070 about one hour after infusion. The blood gas analysis also showed improvement (Table 1 ). Methylene blue infusion was repeated every six hours, guided by arterial blood gas monitoring. Other investigations revealed a haemoglobin of 16.3 g070 (methaemoglobin 26.3070, sulphaemoglobin 1.5070 of total haemoglobin). A peripheral smear showed evidence of haemolysis. Liver function tests and serum electrolytes were within normal limits.
The above treatment was continued for about 36 hours after admission, with improvement in clinical and blood gas parameters. When the arterial haemoglobin saturation reached 95070, methylene blue was discontinued to avoid toxicity and the patient monitored on room air. About twelve hours later he developed jaundice and cyanosis. Repeat investigations showed that the methaemoglobin level had fallen to 407u, with a rise in sulphaemoglobin level to 2.4070. A rise in serum bilirubin and alanine amino transferase (ALT) levels were also observed. (Total bilirubin 51 ILmolll, direct 18.7 ILmollL; ALT: 76 IU/l; alkaline phosphate: 8.0 KAU. (Normal reference values: total bilirubin: 3.4-17 ILmolllitre, direct 0-3.4 ILmolll; ALT: 5-40 IU/litre; alkaline phosphatase 4-13 KAU.) Oxygen therapy by facemask using a high flow and methylene blue therapy were re-commenced. This therapy was continued for a further period of 24 hours until methaemoglobin and sulphaemoglobin levels were within normal limits and arterial oxygen saturation had improved to 99070. The patient was gradually weaned off oxygen therapy and discharged from the ICU. Clinically, the jaundice improved by the sixth day and liver function tests were normal by the tenth day.
DISCUSSION
Dapsone, 4,4 diaminodiphenyl sulphone, is used for treatment of leprosy. It is well absorbed on oral ingestion, with peak levels after two to six hours. The drug can be detected in tissues up to three weeks after ingestion. The half-life normally varies from 9 to 45 hours (mean 30 hours) but in toxic doses may be prolonged to two to four days.
Dapsone produces its major toxic effects directly in the bloodstream where it attacks haemoglobin and the red blood cells. It interacts with haemoglobin to produce methaemoglobin and sulphaemoglobin, resulting in cyanosis. It also reacts with red cell stroma to produce lysis of red cells, as was evident in this case.
Methaemoglobin levels of 15-25070 of total haemoglobin may be associated with cyanosis. Levels of 35-40070 may cause stupor, headache, tachycardia and fatigue and levels over 70070 can be fatal. I In acute dapsone toxicity, initial attempts should be directed towards gut decontamination and improvement of oxygen delivery. Serial levels of dapsone, methaemoglobin and sulphaemoglobin estimation may be used to guide the management. In the present case, gastric lavage was performed and activated charcoal was administered to remove excess dapsone and its metabolites. To improve oxygen delivery, conversion of methaemoglobin to haemoglobin was initiated by administering the reducing agents ascorbic acid and methylene blue. Methylene blue is, however, the antidote of choice. It reduces the half-life of methaemoglobin from 15-20 hours to 40-90 minutes.' Improvement in oxygenation was observed on initiation of methylene blue therapy. A relapse occurred when methylene blue was discontinued. Spurious results may be obtained from pulse oximetry in patients with methaemoglobinaemia who are receiving methylene blue therapy.1O Serial arterial blood gas analysis is therefore advised.
In dapsone overdo sage, sulphaemoglobinaemia may occur later and be associated with continued cyanosis even though methaemoglobin levels might have returned to non-toxic levels. 7 In the present case, a rise in sulphaemoglobin level from 1.5070 to 2.4070 occurred with clinical deterioration, although the methaemoglobin level had fallen from 26.3070 to 4070. Sulphaemoglobin, once formed, is irreversible and remains in circulation till the erythrocyte is destroyed.
Liver involvement has also been reported in patients on dapsone therapy. 8 Blood levels of the drug greater than 2 mg/dl tend to correlate with a greater probability of liver disease. 9 In the present case, hepatic dysfunction leading to jaundice occurred 48 hours after ingestion.
In life-threatening situations, exchange transfusion has also been reported to rapidly reduce the circulating levels of the drug, methaemoglobin and sulphaemoglobin.'1I11
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(1000 U/500 ml) with a continuous-flow device at 3 mllhr. After induction of general anaesthesia a 5.5 French gauge triple-lumen catheter was placed in the right atrium via the right internal jugular vein.
At operation a complicated form of Tetralogy of Fallot was found. The left pulmonary artery was atretic. The pulmonary annulus was hypoplastic and the pulmonary valve was absent. Repair included patching of a large ventricular septal defect and a transannular patch augmentation of the right ventricular outflow tract. Temporary pacing, dopamine (5 mcg/kg/min) and adrenaline (0.1 mcg/kg/min) were required to wean the patient from bypass. She remained ventilated postoperatively in the intensive care unit, attended by our team of nurses trained in intensive care. Dopamine, adrenaline and sodium nitroprusside infusions were maintained via the central line. Systolic blood pressure was maintained at 90 mmHg or greater. One 50 ml bolus of sodium bicarbonate 8.4070 and flucloxacillin six-hourly were given intravenously overnight.
During the first night her left hand was noted to be pale, with poor capillary return. The arterial wave-form which up to this time had been normal, was damped, aspiration of blood from the line was not possible and the cannula was removed. She was extubated about twelve hours postoperatively, and complained of discomfort in the left forearm. Although neither radial
